Previous studies have also suggested that PDL1-positive CTCs were a poor prognostic biomarker in several cancers and that they were highly associated with worse outcome in progression Free Survival (PFS) or overall survival (OS) [37,38,39]. The gene discussed is CD274; the disease is cancer.